Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Neuromodulation for motor recovery after stroke

Official title: CEREBELLO-MOTOR NEUROMODULATION AFTER STROKE

Run by Institut National de la Santé Et de la Recherche Médicale, France · NCT06599931 · Data updated 2026-11-12

This study is testing whether a new brain stimulation technique can help stroke patients recover their movement better than a placebo.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment45 (estimated)
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
Government
Locations2 sites (Paris and 1 other locations)
StatusRecruiting
StartedDecember 13, 2024
Main results expectedJanuary 30, 2027
Study endsDecember 30, 2027
Registry record updatedApril 16, 2026
Trial IDNCT06599931 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have experienced an ischemic stroke or intraparenchymal hematoma more than six months prior, with specific motor deficits.

Probably not a fit

Patients with total paralysis of the affected hand or contraindications to MRI and tACS will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CERSTIM study investigates the effects of transcranial alternating current stimulation (tACS) on the cerebello-motor network in stroke patients. Using a crossover design, the study tests two gamma band frequencies and a placebo to assess their impact on motor recovery. Behavioral data, functional MRI, and electroencephalography will be utilized to understand the mechanisms of tACS. Healthy participants will also be included to provide comparative insights.

Why it matters

Potential benefit: If successful, this approach could enhance motor recovery in stroke patients, improving their quality of life.

How similar studies have gone: While neuromodulation techniques have shown promise in other studies, this specific approach using tACS in the cerebello-motor network is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
PATIENTS

Inclusion Criteria:

* Male or female aged 18 years or older on the day of inclusion.
* Affiliated with a social security system, Universal Health Coverage (CMU), or any equivalent scheme.
* Ischemic stroke or intraparenchymal hematoma that occurred more than 6 months ago, with no upper time limit.
* Motor deficit of the upper limb confirmed by the ARAT scale, with the ability to grip and press on a tablet.
* stroke lesion not affecting the motor cortex in the hand knob area.

Exclusion Criteria:

\-- Pregnant and breastfeeding women

* Total paralysis of the affected hand
* Conditions that are life-threatening or could compromise follow-up during the study period
* Contraindications to MRI and tACS (ferromagnetic surgical clips, ocular implants, intraocular or nervous system metallic foreign bodies, implants or metallic objects likely to concentrate the radiofrequency field, cochlear implants, brain or cardiac stimulators, presence of a craniotomy scar)
* Participation in another biomedical study focused on motor or overall recovery during the same period, or current exclusion period from another biomedical study

HEALTHY

Inclusion Criteria:

* Male or female aged 18 years or older on the day of inclusion.
* Affiliated with a social security system, Universal Health Coverage (CMU), or any equivalent scheme.

Non inclusion criteria

\-- Pregnant and breastfeeding women

* Conditions that are life-threatening or could compromise follow-up during the study period
* Contraindications to MRI and tACS (ferromagnetic surgical clips, ocular implants, intraocular or nervous system metallic foreign bodies, implants or metallic objects likely to concentrate the radiofrequency field, cochlear implants, brain or cardiac stimulators, presence of a craniotomy scar)
* Participation in another biomedical study during the same period, or current exclusion period from another biomedical study

Where it's running

  • ICM_ Institut du Cerveau et de la Moelle épinière, Hôpital Pitié, 47 Bd de l'Hôpital
    Paris, France
    Recruiting
  • ToNIC - Toulouse neuro Imaging center (Inserm)Pavillon Baudot
    Toulouse, France
    Not yet recruiting

Study contacts

  • Principal investigator: Charlotte ROSSO, MD PHD — Institut National de la Santé Et de la Recherche Médicale, France
  • Study coordinator: Charlotte ROSSO, MD PhD
  • Email: charlotte.rosso@aphp.fr
  • Phone: +33142162103

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.